ABC NewsMother Pleads for Direct Organ Donation to Save DaughterPatch.comOn Friday, U.S. Health and Human Services Secretary Kathleen Sebelius requested that Dr. John Roberts, president of the Organ Procurement and Transplantation Network Board, re-eva…
Symphogen Reports New Data on Anti-EGFR Monoclonal Antibody Mixture – PipelineReview.com (press release)
Symphogen Reports New Data on Anti-EGFR Monoclonal Antibody MixturePipelineReview.com (press release)COPENHAGEN, Denmark I June 2, 2013 I Symphogen, a private biopharmaceutical company developing recombinant antibody mixtures, announced today at the 20…
Red Cross explains blood donation process – Stanly News & Press
|
Red Cross explains blood donation process
Stanly News & Press About every two seconds, someone in America needs blood, and one blood donation could help save the lives of up to three people. The American Red Cross conducted a blood drive at South Stanly High School May 17. Newborn babies, cancer patients, car … Red Cross Blood Drive Becoming New RiverFest TraditionKAKE |
Jewish kidney donation saves Palestinian boy – Jerusalem Post
Jewish kidney donation saves Palestinian boyJerusalem PostKidney of 10-year-old who suffered brain death saves Palestinian child; Peres: We are proud of your contribution to peace. Palestinian boy who got a kidney donation from Jewish boy. Photo: Court…
Kuznetsova through to quarters in vintage style – Reuters India
Indian Express |
Kuznetsova through to quarters in vintage style
Reuters India The world number 39, Kuznetsova prevailed after two hours 21 minutes of tennis featuring slides, drop shots and lung-burning rallies, far from the usual baseline-biffing contests in force in women’s tennis. After being broken, Kuznetsova won three … Azarenka revels on shifting sands in ParisTimes of India |
Highlights from ASCO: Bayer's Nexavar; Novartis' Afinitor; and Amgen's … – The Pharma Letter
|
Highlights from ASCO: Bayer’s Nexavar; Novartis’ Afinitor; and Amgen’s …
The Pharma Letter Also at ASCO yesterday, Swiss drug major Novartis (NOVN: VX) presented results from a pivotal Phase III trial of a treatment regimen including Afinitor (everolimus) tablets in women with human epidermal growth factor receptor-2 positive (HER2 positive) … |
Novartis pivotal Phase III trial shows Afinitor significantly delays tumor … – MarketWatch (press release)
|
Novartis pivotal Phase III trial shows Afinitor significantly delays tumor …
MarketWatch (press release) EAST HANOVER, N.J., June 2, 2013 /PRNewswire via COMTEX/ — Novartis today presented results from a pivotal Phase III trial of a treatment regimen including Afinitor� (everolimus) tablets in women with human epidermal growth factor receptor-2 positive … |
Bandra acid attack victim loses battle – Daily News & Analysis
Daily News & Analysis |
Bandra acid attack victim loses battle
Daily News & Analysis She died of multi-organ failure and an eventual cardio respiratory arrest. “Her lungs stopped functioning gradually. Her trachea, vocal cord, food pipe and lungs had been reduced to a lump of soft burnt mass. Since Friday, her kidneys had stopped … |
Ross organ donor targets 700-mile French foray to pay debt of gratitude – Ross-Shire Journal
Ross-Shire Journal |
Ross organ donor targets 700-mile French foray to pay debt of gratitude
Ross-Shire Journal Speaking before setting out, he said: “My motivation for this is to highlight the importance and good work of the renal unit at Raigmore Hospital in Inverness and the importance of organ donation. “It is my hope that I can raise enough funds to … |
New drug that targets lung cancer genes offers better outcome than chemotherapy – Newstrack India
New drug that targets lung cancer genes offers better outcome than chemotherapyNewstrack India2 (ANI): Researchers have found that people, who have an advanced form of lung cancer that carries a specific dysfunctional gene, are likely to fare better if…